Navigation Links
Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
Date:9/3/2009

JERUSALEM, September 3 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that Nadav Kidron, its Chief Executive Officer, is scheduled to present at the Rodman & Renshaw's 11th Annual Healthcare Conference on Friday September 11, 2009 at 10:00 a.m. EDT. The conference will be held at the New York Palace Hotel in New York City.

Nadav Kidron is scheduled to speak in the Fahnestock Salon on the fifth floor of the hotel. He will discuss Oramed's strategic initiatives, updates and product pipeline.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com.

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, tim
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Israels Prestigious Presidents Conference to Feature Oramed Pharmaceuticals Revolutionary Oral Insulin Capsule
2. Oramed Pharmaceuticals to Present Oral Insulin Trial Results at ADA Conference (June 6-10, San Francisco)
3. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
4. Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)
5. Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
6. Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist
7. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ... ... MA (PRWEB) December 14, 2009 -- ThermoFab, a US-based thermoforming ... Tester – helping Brookfield move from sheet metal to a ...
(Date:12/11/2009)... EntreMed, Inc. (Nasdaq: ENMD ), today announced ... from sales of Thalomid® during the third quarter ... In addition, the Company anticipates a decrease ... 2009. The difference in estimated and actual ... in the fourth quarter financial results. ,, (Logo: ...
(Date:12/11/2009)... Colo., December 10, 2009 miRagen Therapeutics, Inc., ... by developing innovative microRNA-based therapeutics for cardiovascular and ... demonstrating that microRNA-206 (miR-206) plays a crucial role ... or Lou Gehrig,s disease) and in neuromuscular synaptic ... the December 11 issue of the journal ...
(Date:12/11/2009)... Boston College researchers have observed the "hot electron" ... and successfully harvested the elusive charges using ultra-thin solar ... efficiency, the authors report in the current online edition ... is captured in solar cells, it generates free electrons ... to snare these charges, the electrons must reach the ...
Breaking Biology Technology:Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2EntreMed Reports Receipt of Third Quarter Royalty Payment 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Elusive 'hot' electrons captured in ultra-thin solar cells 2
... device and technology industries are a major strength of ... the economic health of the state. These industries ... to healthcare technologies and devices. Concentration of this ... producing products and services in the device and technology ...
... Wis. that was organized by ePrairie and the ... geographic locations of high-technology concentration: Madison, Milwaukee and of course ... event (but the first to go on the road), the ... and women come together to meet each other for a ...
... started today. It will be interesting to see if this ... My hunch is that it will not and we will ... about high technology. As in the past, the hall will be ... clueless about what to do. , ,If Governor Doyle ...
Other Biology Technology:Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3Create a Governors Technology Summit 2
(Date:12/11/2009)... ROUGE, LAKeeping with the global "green" trend, ... education lessons to enhance students, science knowledge. ... into the curriculum raises not just science ... scores in other subject areas. Naturally, educators ... integrate these relevant lessons into the classroom ...
(Date:12/11/2009)... green plants photosynthesize, absorb carbon dioxide and produce ... that photosynthesis has had on Earth. One of ... evolution of photosynthesis is Jeffrey Touchman, assistant professor ... , Oxygen, one of the by-products of photosynthesis ... (including algae and higher plants), transformed the Precambrian ...
(Date:12/11/2009)... has granted an 18-month, exclusive option to startup ... analogs. The company must reach certain milestones in ... exclusive license on therapies designed to help patients ... treatments that it hopes will become an important ... market. Insulin is a therapeutic protein used to ...
Breaking Biology News(10 mins):Students learn environmental stewardship, improve science scores 2'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Hormone Therapy for Early Prostate Cancer Not Always Best 55328 1Hormone Therapy for Early Prostate Cancer Not Always Best 55328 2Hormone Therapy for Early Prostate Cancer Not Always Best 55328 3Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 1Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 2Standard 26amp 3B Poor 26apos 3Bs Upgrades Wellmont Outlook 55325 3CareFusion Corp to be Included in S 26P 500 Index 55322 1CareFusion Corp to be Included in S 26P 500 Index 55322 2
... CAMBRIDGE, Mass. (Dec. 15, 2008) Whitehead Institute ... induced pluripotent stem (iPS) cells, cutting the number ... four to one. Scientists hope that these embryonic ... such ailments as Parkinson,s disease and diabetes. , ...
... for the treatment of conditions such as arthritis, osteoporosis, ... and cartilage currently produced in the laboratory don,t have ... not clinically viable. Dr. Douglas Hamilton, a dental ... at The University of Western Ontario has received funding ...
... of youths with type 1 diabetes were found to have ... researchers at the Joslin Diabetes Center findings that suggest ... prevent bone fragility later in life. , "To our surprise, ... Lori Laffel, M.D., M.P.H., Chief of the Pediatric, Adolescent and ...
Other Biology News:Single virus used to convert adult cells to embryonic stem cell-like cells 2Building better bones and tissue in the lab 2Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D 2
...
... Polypropylene Rotor designed for use in ... and Centra-MP4/MP4R*. A translucent lid is ... polypropylene rotor design provides excellent chemical ... Polypropylene rotors are fully compatible ...
... a powerful technology platform that automates gel ... High quality sample preparation can be carried ... Xcise is a powerful technology platform that ... analysis. It combines the functions of high-resolution ...
Request Info...
Biology Products: